IBC6:XETRA:XETRA-iShares MSCI Australia UCITS (EUR)

ETF | Others |

Last Closing

USD 49.615

Change

+0.07 (+0.13)%

Market Cap

USD 0.41B

Volume

3.53K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.06 (-0.11%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.15%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.10 (-0.39%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.12 (-0.08%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.10%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.11 (-0.22%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.27 (-0.28%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.66 (-0.12%)

USD 80.38B

ETFs Containing IBC6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.45% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.45% 63% D 64% D
Trailing 12 Months  
Capital Gain 25.43% 78% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.43% 78% C+ 76% C+
Trailing 5 Years  
Capital Gain 51.94% 66% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 51.94% 65% D 65% D
Average Annual (5 Year Horizon)  
Capital Gain 10.47% N/A N/A 70% C-
Dividend Return 10.47% N/A N/A 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.58% N/A N/A 50% F
Risk Adjusted Return 71.79% N/A N/A 75% C
Market Capitalization 0.41B 61% D- 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike